Market Cap 75.76M
Revenue (ttm) 0.00
Net Income (ttm) -77.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 696,600
Avg Vol 699,576
Day's Range N/A - N/A
Shares Out 42.80M
Stochastic %K 2%
Beta 2.01
Analysts Strong Sell
Price Target $11.50

Company Profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 207 8979
Website: acrivon.com
Address:
480 Arsenal Way, Suite 100, Watertown, United States
Trinity031983
Trinity031983 May. 17 at 1:59 AM
0 · Reply
SkullInferno
SkullInferno May. 15 at 9:35 PM
0 · Reply
nmarrone2207
nmarrone2207 May. 15 at 9:30 PM
$ACRV did Citadel exit today? Or is there something else to that filing??
1 · Reply
MrTicker
MrTicker May. 15 at 8:03 PM
$ACRV Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GLOBENEWSWIRE 3:00 PM ET 5/15/2026
0 · Reply
Dani_G_German
Dani_G_German May. 15 at 7:14 PM
$ACRV I added again today
0 · Reply
aquira
aquira May. 15 at 3:32 PM
$ACRV fooken helllll. Looks like we're going back down to around 1.2-1.35 area and stay there for 6 months to 1 year. Foooken frustrating. I should've sold at 2.17. I foooken knew it
1 · Reply
Trinity031983
Trinity031983 May. 15 at 2:07 PM
0 · Reply
Trinity031983
Trinity031983 May. 15 at 2:05 PM
0 · Reply
Monty3030
Monty3030 May. 14 at 4:31 PM
$ACRV Check out this article from TipRanks | Analyst Reiterates Buy on Acrivon, Maintains $19.X Price Target Amid Progress of ACR-368 Trials | https://tipranks.onelink.me/WJho/awc68vlw
0 · Reply
Dani_G_German
Dani_G_German May. 13 at 9:59 PM
$ACRV it’s gonna be a great year for us. There’s a lot of strong data set to be released and we are fully funded into late ‘27. Even if they decide to raise money to solidify their future it would be extremely bullish at this stage and in the future. Remember, they have no debt.! And a proprietary ai driven software. Imo under $2 is load zone GL
0 · Reply
Latest News on ACRV
Acrivon Therapeutics reports Q1 EPS (49c), consensus (52c)

2026-05-13T21:27:56.000Z - 4 days ago

Acrivon Therapeutics reports Q1 EPS (49c), consensus (52c)


Acrivon Therapeutics reports Q4 EPS (49c), consensus (46c)

2026-03-19T11:25:53.000Z - 2 months ago

Acrivon Therapeutics reports Q4 EPS (49c), consensus (46c)


Acrivon Therapeutics sees cash runway into 2Q27

2026-03-19T11:25:40.000Z - 2 months ago

Acrivon Therapeutics sees cash runway into 2Q27


Acrivon Therapeutics Transcript: Study Update

Jan 8, 2026, 8:30 AM EST - 4 months ago

Acrivon Therapeutics Transcript: Study Update


Acrivon Therapeutics announces progress across pipeline

2026-01-08T12:35:54.000Z - 4 months ago

Acrivon Therapeutics announces progress across pipeline


Acrivon to provide ACR-368, ACR-2316 clinical data in January

2025-12-17T12:36:13.000Z - 5 months ago

Acrivon to provide ACR-368, ACR-2316 clinical data in January


Acrivon Therapeutics reports Q3 EPS (47c), consensus (58c)

2025-11-13T21:50:27.000Z - 6 months ago

Acrivon Therapeutics reports Q3 EPS (47c), consensus (58c)


Acrivon Therapeutics reports Q2 EPS (55c), consensus (58c)

2025-08-13T20:45:13.000Z - 9 months ago

Acrivon Therapeutics reports Q2 EPS (55c), consensus (58c)


Acrivon Therapeutics  reports Q1 EPS (51c), consensus (65c)

2025-05-14T20:36:53.000Z - 1 year ago

Acrivon Therapeutics reports Q1 EPS (51c), consensus (65c)


Acrivon Therapeutics Transcript: Status Update

Mar 25, 2025, 4:00 PM EDT - 1 year ago

Acrivon Therapeutics Transcript: Status Update


Acrivon Therapeutics Transcript: Study Update

Sep 14, 2024, 9:00 AM EDT - 1 year ago

Acrivon Therapeutics Transcript: Study Update


Acrivon Therapeutics Transcript: R&D Update

Apr 24, 2024, 4:15 PM EDT - 2 years ago

Acrivon Therapeutics Transcript: R&D Update


Acrivon Therapeutics sets IPO price range

Nov 3, 2022, 7:52 AM EDT - 3 years ago

Acrivon Therapeutics sets IPO price range


Trinity031983
Trinity031983 May. 17 at 1:59 AM
0 · Reply
SkullInferno
SkullInferno May. 15 at 9:35 PM
0 · Reply
nmarrone2207
nmarrone2207 May. 15 at 9:30 PM
$ACRV did Citadel exit today? Or is there something else to that filing??
1 · Reply
MrTicker
MrTicker May. 15 at 8:03 PM
$ACRV Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GLOBENEWSWIRE 3:00 PM ET 5/15/2026
0 · Reply
Dani_G_German
Dani_G_German May. 15 at 7:14 PM
$ACRV I added again today
0 · Reply
aquira
aquira May. 15 at 3:32 PM
$ACRV fooken helllll. Looks like we're going back down to around 1.2-1.35 area and stay there for 6 months to 1 year. Foooken frustrating. I should've sold at 2.17. I foooken knew it
1 · Reply
Trinity031983
Trinity031983 May. 15 at 2:07 PM
0 · Reply
Trinity031983
Trinity031983 May. 15 at 2:05 PM
0 · Reply
Monty3030
Monty3030 May. 14 at 4:31 PM
$ACRV Check out this article from TipRanks | Analyst Reiterates Buy on Acrivon, Maintains $19.X Price Target Amid Progress of ACR-368 Trials | https://tipranks.onelink.me/WJho/awc68vlw
0 · Reply
Dani_G_German
Dani_G_German May. 13 at 9:59 PM
$ACRV it’s gonna be a great year for us. There’s a lot of strong data set to be released and we are fully funded into late ‘27. Even if they decide to raise money to solidify their future it would be extremely bullish at this stage and in the future. Remember, they have no debt.! And a proprietary ai driven software. Imo under $2 is load zone GL
0 · Reply
Dou_said_it
Dou_said_it May. 13 at 9:14 PM
$ACRV hello, please, on which plateforme other as Revolut can i buy ACRV? On revolut i can’t Thanks
2 · Reply
Monty3030
Monty3030 May. 13 at 8:50 PM
0 · Reply
open_outcry
open_outcry May. 13 at 8:33 PM
$ACRV https://www.stocktitan.net/news/ACRV/acrivon-reports-first-quarter-2026-financial-results-and-highlights-n14d0k6ehii3.html gotta love an oncology biotech with multiple promising candidates, a large and growing investment from RA Capital Mgmt, and cash equivalents that surpass market cap.
0 · Reply
open_outcry
open_outcry May. 13 at 7:04 PM
$ACRV very calm pre-EC...
0 · Reply
Dani_G_German
Dani_G_German May. 13 at 5:54 PM
$ACRV I’m buying more here
1 · Reply
PreGigs
PreGigs May. 11 at 6:16 PM
$ACRV just buying the dips in the background lol
0 · Reply
blackpoint01
blackpoint01 May. 11 at 6:07 PM
$ACRV everyone quite as hell 😂.
0 · Reply
Dani_G_German
Dani_G_German May. 5 at 8:44 PM
$ACRV down .09 today just to be up .20 tomorrow
0 · Reply
outrighthavoc
outrighthavoc May. 5 at 7:22 PM
0 · Reply
aquira
aquira May. 5 at 2:02 PM
$ACRV what the actual forkkkkkkkkk
0 · Reply
Dou_said_it
Dou_said_it May. 5 at 7:41 AM
$ACRV Hope that soon… june or july
0 · Reply
blackpoint01
blackpoint01 May. 4 at 8:13 PM
$ACRV one day I hope to wake up at $10
0 · Reply